Clinical outcomes following ibrutinib and idelalisib-based therapy in CLL: A retrospective analysis - Regional Cancer Care Associates LLC

Clinical Trials

Clinical outcomes following ibrutinib and idelalisib-based therapy in CLL: A retrospective analysis

Type of Cancer
Lymphoma
Locations
Hackensack
Sponsor
Hackensack UMC
Protocol Number
Hackensack UMC PRO 00005855
Cancer Diagnosis
To Learn More Call
201-510-0910